Publication Database

The publication database contains all articles from HZI staff (formerly GBF) starting with year 2000.

 

Werbenko,E., Gorter,D.J.J., Kleimann,S., Beckmann,D., Waltereit-Kracke,V., Reinhardt,J., Geers,F., Paruzel,P., Hansen,U., Pap,T., ... , Stradal,T.E.B., Dankbar,B. (2024)
Hem1 is essential for ruffled border formation in osteoclasts and efficient bone resorption
Scientific Reports 14 (1)
Zhao,S., Feng,R., Gu,Y., Han,L., Cong,X., Liu,Y., Liu,S., Shen,Q., ... , Huo,L., Yan,F. (2023)
Heterologous expression facilitates the discovery and characterization of marine microbial natural products
Engineering Microbiology 4 (2)
Zou,M., Pezoldt,J., Mohr,J., Philipsen,L., Leufgen,A., Cerovic,V., Wiechers,C., Pils,M., Ortiz,D., Hao,L., Yang,J., Beckstette,M., Dupont,A., Hornef,M., Dersch,P., Strowig,T., Müller,A.J., ... , Raila,J., Huehn,J. (2024)
Early-life vitamin A treatment rescues neonatal infection-induced durably impaired tolerogenic properties of celiac lymph nodes
Cell Reports 43 (5)
Richter,C., Neu,T., Latta,L., Schneider-Daum,N., Lehr,C.-M. (2024)
Cell-based in vitro models for pulmonary permeability studies
2. edition (3.5)
Khalifa,H., Rasheed,S., Haupenthal,J., Herrmann,J., Mandour,Y.M., Abadi,A.H., Engel,M., Müller,R., Hirsch,A.K.H., ... , Abdel-Halim,M., Hamed,M.M. (2024)
Development and evaluation of 2,4-disubstituted-5-aryl pyrimidine derivatives as antibacterial agents
Arch.Pharm. 357 (4)
Freilinger,S., Kaemmerer,H., Pittrow,R.D., Achenbach,S., Baldus,S., Dewald,O., Ewert,P., Freiberger,A., Gorenflo,M., Harig,F., Hohmann,C., Holdenrieder,S., Hörer,J., Huntgeburth,M., Hübler,M., Kohls,N., Klawonn,F., Kozlik-Feldmann,R., Kaulitz,R., Loßnitzer,D., Mellert,F., Nagdyman,N., Nordmeyer,J., Pittrow,B.A., Pittrow,L.B., Rickers,C., Rosenkranz,S., Schelling,J., Sinning,C., Suleiman,M.N., von Kodolitsch,Y., ... , von Scheidt,F., Kaemmerer-Suleiman,A.S. (2024)
PATHFINDER-CHD: prospective registry on adults with congenital heart disease, abnormal ventricular function, and/or heart failure as a foundation for establishing rehabilitative, prehabilitative, preventive, and health-promoting measures: rationale, aims, design and methods
BMC Cardiovasc.Disord. 24 (1)
Chen,X., Zhao,H., Wang,C., Hamed,M., Shang,Q., Yang,Y., Diao,X., Sun,X., Hu,W., Jiang,X., Zhang,Y., Hirsch,A.K.H., ... , Wu,D., Zhuang,J. (2024)
Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes
Int.J.Antimicrob.Agents
Hillenbrand,M., Esslinger,C., Seidenberg,J., Weber,M., Zingg,A., Townsend,C., Eicher,B., Rutkauskaite,J., Riese,P., Guzman,C.A., ... , Fischer,K., Schmitt,S. (2024)
Fast-Track Discovery of SARS-CoV-2-Neutralizing Antibodies from Human B Cells by Direct Functional Screening
Viruses. 16 (3)
Ponath,F., Zhu,Y., Vogel,J. (2024)
Transcriptome fine-mapping in Fusobacterium nucleatum reveals FoxJ, a new s(
MBio.
Becker,T., Heitkötter,J., Krome,A.K., Schiefer,A., Pfarr,K., Ehrens,A., Grosse,M., Sandargo,B., Stammberger,I., Stadler,M., Hübner,M.P., Kehraus,S., ... , Hoerauf,A., Wagner,K.G. (2024)
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations
Pharmaceutics. 16 (3)